The International Neuropsychiatric Association (INA) was originally established by Spanish and American neuropsychiatrists in Seville in 1996 as the International Organisation of Neuropsychiatry.
Founding Committee
- Dr Barry S. Fogel Brown University, USA
- Dr Moises Gaviria University of Illinois at Chicago, USA
- Dr Jose Giner The University of Seville, Spain
- Dr Robert Green Emory University School of Medicine, USA
The committee proposed establishing an international organisation, noting that:
“Neuropsychiatry is a burgeoning discipline not only in the United States, but also worldwide.”
In 1996, following the second meeting in Toronto, the organisation’s name was changed to the International Neuropsychiatric Association.
Since then, the INA has held international meetings every two years in different countries, usually in association with a psychiatric organisation from the host country.
At each meeting, two distinguished academics are invited to present:
- The Alwyn Lishman Lecture Focused on clinical neuropsychiatry.
- The Ramon y Cajal Lecture Focused on neuroscience relevant to neuropsychiatry.
Aims
Using its global reach, the INA aims to:
- Provide an international forum for the exchange of knowledge among clinicians and academics working in neuropsychiatry, helping to improve the understanding and treatment of brain–behaviour disorders.
- Publicise and disseminate clinical and academic advances in neuropsychiatry to support improved health outcomes for people throughout the world.
- Raise awareness of neuropsychiatry, particularly in countries where the discipline is not widely known or recognised.
Activities
- Organises a biennial international meeting.
- Supports regional meetings and professional collaboration.
The INA is unable to provide clinical advice to individuals, carers or families.
